Skip to main content
. 2022 Jan 18;12:795214. doi: 10.3389/fphar.2021.795214

FIGURE 4.

FIGURE 4

Any adverse events with vadadustat versus placebo or darbepoetin alfa. EAS, erythropoiesis-stimulating agent, only darbepoetin alfa. The registration number of Nangaku (NDD) 2020 corresponds to NCT03054337, Nangaku (DD) 2020 corresponds to NCT03054350, Chertow (ESA-untreated) 2021 corresponds to NCT02648347, Chertow (ESA treated) 2021 corresponds to NCT02680574, Eckardt (incident DD) 2021 corresponds to NCT02865850, Eckardt (prevalent DD) 2021 corresponds to NCT02892149, Nangaku (NDD) 2021 corresponds to NCT03329196, Nangaku (DD) 2021 corresponds to NCT03439137.